Terug
Dagbereik
€ 15,36
€ 16,13
52-Weeksbereik
€ 13,83
€ 36,91
Volume
2.029.714
50D / 200D Gem.
€ 15,90
/
€ 19,97
Vorige Slotkoers
€ 15,60
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -10,7 | 0,3 |
| P/B | 17,6 | 2,9 |
| ROE % | -206,1 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 26,00
+67.3%
Low: € 16,00
High: € 40,00
Forward WPA
-€ 1,15
Omzet Sch.
8,6 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,89
€ 0,13 – € 4,60
|
4,4 B | 2 |
| FY2029 |
€ 0,65
€ 0,05 – € 1,58
|
2,5 B | 4 |
| FY2028 |
-€ 0,02
-€ 0,15 – € 0,20
|
940 M | 6 |
Belangrijkste Punten
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -323,59M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-206,10%
ROIC-90,33%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,02
Current Ratio9,87
Interest Coverage0,00
Waardering
P/E Ratio
-10,72
P/B Ratio17,56
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -1,08B |
| ROE | -206,10% | ROA | -143,72% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -323,59M |
| ROIC | -90,33% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 9,87 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -10,72 | P/B Ratio | 17,56 |
| P/S Ratio | N/A | PEG Ratio | -0,03 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 11,57B | Enterprise Value | 11,36B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 704.295,0 | 1,81M |
| Net Income | -1,08B | -221,32M | -614,93M | -78,78M | -88,60M |
| EPS (Diluted) | -1,44 | -0,31 | -0,99 | -0,38 | -0,96 |
| Gross Profit | -108.355,0 | -15,01M | -2,05M | -1,81M | 1,81M |
| Operating Income | -812,24M | 313.000,0 | -89,74M | -59,63M | -86,19M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 751,18M | 435,56M | 202,95M | 664,17M | 113,37M |
| Total Liabilities | 92,32M | 46,81M | 125,26M | 537,51M | 30,09M |
| Shareholders' Equity | 658,86M | 388,75M | 77,69M | 126,65M | 83,28M |
| Total Debt | 15,50M | 7,22M | 106,10M | 518,76M | 2,78M |
| Cash & Equivalents | 225,27M | 104,86M | 71,43M | 348,61M | 71,79M |
| Current Assets | 720,30M | 423,75M | 189,71M | 656,71M | 97,31M |
| Current Liabilities | 72,99M | 41,73M | 20,41M | 38,78M | 25,62M |